Research coauthored by RTI Health Solutions researchers will be presented at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO 2022).
Health-related quality of life and tolerability in patients with/without skin toxicity during loncastuximab tesirine treatment in a phase 2 clinical trial (LOTIS-2). Spira A, Zhou X, Liao L, Yu E, Chen L, Lau A, Wang Y, Gnanasakthy A, Radford J, Hamadani M.
